EVERENCE CAPITAL MANAGEMENT INC – Regeneron Pharmaceuticals, Inc. Transaction History
EVERENCE CAPITAL MANAGEMENT INC portfolio value:
$2.52M
portfolio value
EVERENCE CAPITAL MANAGEMENT INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +18.38% | 570 shares | 696K | $688.87 | 3.67K |
| Q2 2022 | share | 0.00% | 0 shares | -333K | $591.13 | 3.10K | |
| Q1 2022 | share | 0.00% | 0 shares | 208K | $698.42 | 3.10K | |
| Q4 2021 | share | Increase | +23.99% | 600 shares | 444K | $642.51 | 3.10K |
| Q3 2021 | share | 0.00% | 0 shares | 117K | $605.18 | 2.50K | |
| Q2 2021 | share | 0.00% | 0 shares | 214K | $558.54 | 2.50K | |
| Q1 2021 | share | 0.00% | 0 shares | -25K | $473.14 | 2.50K | |
| Q4 2020 | share | Increase | +11.60% | 260 shares | -46K | $483.11 | 2.50K |
| Q3 2020 | share | Increase | +0.90% | 20 shares | -107K | $559.78 | 2.24K |
| Q2 2020 | share | 0.00% | 0 shares | 277K | $623.65 | 2.22K | |
| Q1 2020 | share | 0.00% | 0 shares | 250K | $488.29 | 2.22K | |
| Q4 2019 | share | Increase | +42.28% | 660 shares | 401K | $375.48 | 2.22K |
| Q3 2019 | share | 0.00% | 0 shares | -56K | $277.4 | 1.56K | |
| Q2 2019 | share | 0.00% | 0 shares | -152K | $313 | 1.56K | |
| Q1 2019 | share | Decrease | -10.13% | -176 shares | -8K | $410.62 | 1.56K |
| Q4 2018 | share | 0.00% | 0 shares | -53K | $373.5 | 1.73K | |
| Q3 2018 | share | 0.00% | 0 shares | 103K | $404.04 | 1.73K | |
| Q2 2018 | share | 0.00% | 0 shares | 1K | $344.99 | 1.73K | |
| Q1 2018 | share | 0.00% | 0 shares | -55K | $344.36 | 1.73K | |
| Q4 2017 | share | 0.00% | 0 shares | -124K | $375.96 | 1.73K | |
| Q3 2017 | share | Increase | +41.56% | 510 shares | 174K | $447.12 | 1.73K |
| Q2 2017 | share | 0.00% | 0 shares | 128K | $491.14 | 1.22K | |
| Q1 2017 | share | 0.00% | 0 shares | 25K | $387.51 | 1.22K | |
| Q4 2016 | share | Decrease | -30.36% | -535 shares | -258K | $367.09 | 1.22K |
| Q3 2016 | share | 0.00% | 0 shares | 93K | $402.02 | 1.76K | |
| Q2 2016 | share | 0.00% | 0 shares | -20K | $349.23 | 1.76K | |
| Q1 2016 | share | 0.00% | 0 shares | -322K | $360.44 | 1.76K |